Determined by its unique chemical property, NO reacts with many sites on intracellular molecules and hence affects a plethora of oncogenic pathways, such as tumor suppressor inactivation as suggested for PTEN in these studies, supporting consideration of NOS/NO targeted anti-cancer therapeutics (30). The gene discussed is NOS2; the disease is cancer.